ARCHIVES

ODAC Recommends Iressa Approval As Third-Line Lung Cancer Treatment

This article is from The Cancer Letter archive.

Vol. 28 No. 35 | September 27, 2002

Download PDF Visit The Full Archive

Related Articles

AACI Statement On Cancer Centers Presented to Reform Task Force

April 9, 1993

New Drugs Improve Outlook For Bone Marrow Cancer

March 31, 2006

NCI CTEP Approved Trials For the Month of February

February 22, 2013

NCI Announces Designation Of Comprehensive Center

July 20, 1990

Immunotherapy Shrinks Tumors In Phase I Study at St. Jude

May 30, 2014

NIH Considering Intramural NRSA, NCI Advisors Not Enthusiastic

February 17, 1984